Pharma IPR Conference
February 15, 2024, 6:43 PM
Axinn is proud to be a Platinum Partner of the Pharma IPR Conference
- On March 5 at 11:00 AM, partners Aziz Burgy, Ted Mathias, and counsel Rebecca Clegg are excited to conduct a panel discussion covering “Polymorph Patents: Infringement and Invalidity Challenges.”
We Know Pharma … and They Know Us
Axinn is the go-to firm for IP matters of strategic importance and offers one of the leading pharmaceutical practices in the country. Our team combines its depth of substantive patent law and litigation experience with FDA and antitrust knowledge to offer clients a unique and holistic offering. Whether leading a patent trial on a blockbuster product or navigating the complex FDA regulatory regime, Axinn enables pharmaceutical clients to bring their products to market in the most profitable manner possible.
We've worked on some of the most successful products in the pharmaceutical industry representing over $30 billion in annual sales, including:

Extensive Pharmaceutical Industry Experience

Contact Us
Please reach out to any of our attorneys attending the conference. You can set up a time to meet with an individual attorney using the email link in their contact details.
| Aziz Burgy Partner aburgy@axinn.com | Rebecca Clegg Counsel rclegg@axinn.com | ||
| Ted Mathias Partner tmathias@axinn.com |

To subscribe to our publications, click here.
Tags
News & Insights
News & Insights
CCWC 22nd Annual Career Strategies Conference
Sponsorship
Fordham Competition Law Institute's 53rd Annual Conference on International Antitrust Law and Policy, and Antitrust Economics Workshop
Sponsorship
Antitrust
Women, Influence, & Power in Law Conference 2026
Sponsorship
Antitrust
IP Litigation North America Summit 2026
Sponsorship
Intellectual Property
HNBA/VIA Annual Convention 2026
Sponsorship
Antitrust
30th Annual IBA Competition Conference
Speaking Engagement
Antitrust
ABA 2026 Antitrust Global Seminar Series
Speaking Engagement
Antitrust
Axinn Attorneys Earn Top Honors in Best Lawyers 2027
News
Antitrust
DOJ's Antitrust Division Remains Interested in Your Private Litigation
Byline Articles
Antitrust
Axinn Advises Thermo Fisher Scientific on Completed $1.075 Billion Sale of Microbiology Business to Astorg
Deals & Cases
Antitrust